Link : http://www.prweb.com/releases/2012/1/prweb9129379.htm
Very interesting stuff. It seems that Aderans (ARI) was expanding their Phase 2 study to the extend of looking at all thinkable outcomes and mixtures.
There is a huge potential that that ARI will have a very short Phase 3 trial.
It also seems that people on a NW scale from 2 to 5 could be really happy again.
hairmultiplicationnews 